Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by QContinuum1on Nov 04, 2024 1:32pm
77 Views
Post# 36295640

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Teuto or Verdemed?

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Teuto or Verdemed?
Lemoyne wrote:
Unless you are close to the founders or LABS mgmt, I wouldn't make assumptions like that. Strategically, LABS has always been focused on the pharma side/ intl markets. And I believe most of those decisions were made or partially made by Keith. Because well, STADA was worked on and announced way before the arrival of Pidduck, Hunter or Taves. Maybe you are discounting Keiths role more than you should.

- 60k ain't gonna cut it for Keith. 100% sure of that. Also, he mentioned he was excited to work with and integrate Remidose only 5 months ago.

- Hope Facility, those specialty websites are publicly accessible. Yes the buyers are vetted, but the listing can be found by anyone. Because well, you want the information on those facilities to reach to as many people as you can.

- Debt: LABS could've refinanced, as most mj businesses do, especially since LABS has a solid balance sheet. Not because it's due that it's impossible to renegotiate terms.

Imo, they should definetely shop the business to big pharma and mj businesses. It's current valuation is irrelevant if they have solid contracts with numbers to show for in terms of sales (especially generic sales). As I said before, if LABS mgmt thinks they can reach a reasonable deal where they give up some value to offset certain risks, good on them. Shareholders will then be able to vote.



FWIW, no doubt the pivot to pharma was done by Pat/Keith.  That was as shrewd a move as they could have made back then and it was a good one.  The business would have rolled over by now if not for that decision.  Don't think myself that the decisions that followed ex-Pidduck/Hunter have been all that great however, so I think there is some deserved stink eye to be given to Strachan and some of the old guard.  Sure Stada looked like a massive whale landing at the time, but that 'deal' hasn't amounted to a hill of beans in the years (yes years) since.  If Stada is this powerhouse in Europe, Medipharm ought to have benefited, but I haven't heard or seen it yet.

Doubt we'll ever know why Strachan got shuffled, but ELT members don't just, on their own, give up a salary shy of 6 zeros.  So it really was a face-saving, lawsuit avoiding shuffle to the Board OR it was something far more lucrative and beneficial for all.  One thing is for sure, something needs to give soon or this business will find itself forever on the irrelevant heap as the competition eats its lunch.
<< Previous
Bullboard Posts
Next >>